CAS 70024-90-7 Recombinant Human Albumin HSA With Less Than 0.125EU/Mg Endotoxin

CAS 70024-90-7 Recombinant Human Serum Albumin HSA With Less Than 0.125EU/mg Endotoxin ​

Quick detail

1. Amino Acids Sequence:the same with pHSA
2. N-terminus:DAHKSEV
3. C-terminus:KLVAASQAALGL
4. Glycosylation:No
5. PI:4.8
6. Thermal Stability:M/P 65℃
7. Lipid Conjugation:the same with pHSA
8. Crystal Structure:the same with pHSA

Description

Endotoxin is a gram-negative bacterium in the cell wall of a component known as lipopolysaccharide. Endotoxin is not a protein, so it is very heat-resistant. Therefore, developing, manufacturing and marketing low endotoxin products are very necessary.In order to remove the endotoxin from the rHSA,the purify processing of rHSA conatins differednt steps of Chromatography columns. Our rHSA endotoxin is less than 0.25 EU / mg.Our low endotoxin rHSA is very useful for the biotechnology research and production.

Advantages 

1. Healthgen Biotechnology Corp. is a private company founded in 2006. We specialize in molecular pharmaceutical technology research and high-tech innovation-oriented product development, which is developing, manufacturing and marketing a series of recombinant proteins and growth factors by rice endosperm platform. We have 400 square meters of research center, in which 30% of the research personnels have doctoral degree and major in different directions of the research and development. Healthgen has strong capability in developing a series of biological products.

2. The rice endosperm specific expression platform is easy to be large-scale. The rice endosperm has the protein body, which can keeps proteins stability and bioactivity.

At present, the production capacity is almost 1000 kg / year.

3. Recombinant human serum albumin (rHSA) has good efficacy, such as rHSA has the same second and tertiary structure, physiological and biochemical properties with HAS from plasma. In addition, compared with HSA from plasma, rHSA has a lower immune source stimulation, and plays a better role in accelerating cell growth and metabolism, because rHSA is animal component free, which can avoid the prions or virus contaminants.

Supplemental Description

Due to the potential existence of various infectious disease pathogens in the human blood, especially AIDS, hepatitis B and other viruses. Thereby, these virus from human plasma will be brought with HSA to the final products. rHSA produced by gene recombinant technology can effectlively avoid the risks of virus pollution and infection. What’s more, the supply of human blood is limited. Therefore, it’s very urgent to search blood substitutes. The establishment and development of recombinant DNA technology provide an important method for the acquisition of biological materials. In recent years, many researchers have been hotly committed to the recombinant human serum albumin research.